The Central government announced the Padma Awards on the eve of the country’s 73rd Republic Day. Our President Ram Nath Kovind affirmed 128 recipients of Padma Awardees in three categories..
Padma Vibhushan (7), Padma Bhushan (17), Padma Shri (107).
Krishna Ella & Suchitra Ella from Telangana – Padma Bhushan (Trade and Industry)
Covaxin’s Chairman Krishna and Joint Managing Director Suchitra garu are awarded with Padma Bhushan for their tremendous contribution towards making the covid vaccine.
World lo 70 % population ki vaccine ni produce chese capabilities only mana India ke undi, India lo vaccine kosam work chesthuna companies lo mana Hyderabad based companies eh ekkuva unnai, ippudu Indian vaccination mission lo key role play chesthunna mana made in India Covaxin kuda Hyderabad based company Bharat Biotech company nunchi vachindhe..
Dr Krishna Ella, founder of Bharat Biotech
Middle class farmer family nunchi vachina Krishna Ella, Andhra Pradesh and Tamil Nadu border dhagara unde Thiruthani area nunchi vacharu, chinnapudu thanaki traditional farming cheyalani unna valla father korika tho vere profession ni choose cheskunnaru..
University of Agricultural Sciences, Bangalore, lo thanu graduate ayi, tharvatha MS kosam US lo University of Hawaii ki vellaru..
University of Wisconsin Madison lo PhD chesi tharvatha Medical University lo South Carolina, Charleston, lo work chesaru..
Never found his heart enjoying the work at a foreign land.
Foreign lo entha work chesina enni sampadinchina heartful ga enjoy cheyalekapoayaru, anni vadhilesi thana wife Suchitra garu tho 1996 lo India ki vachesaru, tharvatha ikkada Hyderabad lo 12.5 crores tho Bharat Biotech International Limited company establish chesaru..
12 crore tho start chesina Bharat Biotech worth ippudu more than 500 crore tho more than thousand employees strength tho undi, more than 150 countries ki UNICEF, GAVI distribution channels dhwara underprivileged people ki more than 4 billion vaccine doses ni delivery chesthundi..
On the other hand, his wife and Joint Managing director of Bharat Biotech, Suchitra Ella full support and guidance isthu Bharat ki strong pillar ga nilicharu. She overseas a wide range of operations in the company. She also have a vast experiece incustomer operations, finance and marketing business.
Largest company in the developing world with the highest number of clinical trails..
Indian Council of Medical Research (ICMR)and National Institute of Virology (NIV) collaboration tho Covaxin ni thayaru chesaru. July 2020 lo DCGI approval tho phase 1 and phase 2 human clinical trails ni chesaru, tharvatha 25 centers lo around 26,000 participants tho phase 3 trails ni kuda conduct chesaru..
Safety of COVAXIN
After approval Covaxin for emergency usage Dr Krishna Ella garu said that, “We took vero cell culture at coronavirus vaccine platform. All our vaccines which we are producing are at the same platform. It is the safest and easiest platform and safety can be proven very easily.“
Covaxin is an inactivated vaccine developed and manufactured in the company’s BSL (Bio Safety Level ) bio containment facility. He explained that Bharat Biotech is the “only one with BSL production facility, a facility the US has only started building now in Kansas“,
Vaccines from Bharat Biotech, Before Covaxin
Covaxin kanna mundhu Bharat Biotech H1N1, Chikungunya, Zika, Rotavirus, Rabies and Japanese Encephalitis ki vaccines produce chesindi, Typhoid ki world lo first tetanus toxoid conjugated vaccine ni kuda thayaru chesindi ee team researchers eh..
Successfully launched Typbar TCV, the 1st clinically proven and WHO pre qualified Typhoid Conjugate Vaccine (TCV) in the world, which can be administered to even a six month old baby.
India’s own global company.
Bharat Biotech has 140 global patents to its name and a product portfolio of more than 16 vaccines. It has successfully developed Rotavac, the most affordable vaccine against rotavirus induced diarrhoeal infections and death in the world.
If you wish to contribute, mail us at firstname.lastname@example.org